Plain-English translation of NCT06957093 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new artificial intelligence-based diabetes management platform designed to help people with type 2 diabetes better control their blood sugar and overall health. If you're in the AI group, you'll use a smartphone app that receives data from a blood sugar meter and fitness tracker, then gives you personalized feedback and reminders about your medications, diet, and exercise. The study will compare how well this new approach works compared to standard diabetes care over one year.
Many people with type 2 diabetes struggle to manage their condition on their own, and doctors are looking for better ways to help patients stay on track with their medications and lifestyle changes. This trial is testing whether using artificial intelligence to provide personalized, automatic feedback and monitoring could help patients do better than traditional office visits alone.
You likely qualify if…
You likely don't qualify if…
You'll start with an initial visit for blood tests, vital signs, and health history, then be assigned to either the AI app group or the standard care group. If you're in the AI group, you'll receive training on how to use the app, a blood sugar meter, and a fitness tracker—all data uploads happen automatically through Bluetooth. Over 48 weeks (about one year), you'll have follow-up visits every 12 weeks, and the AI platform will send you personalized feedback every two weeks based on your blood sugar, diet, and exercise data. The standard care group will simply receive a blood sugar meter and attend clinic visits every 12 weeks.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China